Taobao will support WeChat Pay. WeChat Pay response: The compatibility between WeChat Pay and Taobao platform merchants is currently being opened.
In response to the comprehensive entry into Taobao, WeChat Pay responded that the functionality compatibility with Taobao platform merchants is currently being opened, please pay attention to the Taobao platform announcement for the specific online time.
On the afternoon of September 4th, Taobao released a "Consultation on the Addition of WeChat Payment Capability to Taobao", stating that in order to enhance the shopping experience for consumers, Taobao plans to add WeChat payment capability. Based on this new service, Taobao intends to make adjustments to its platform rules. In response to the full integration into Taobao, WeChat payment stated that compatibility with Taobao platform merchants is currently being opened, and the specific launch time will be announced in Taobao's platform notice.
Additionally, a spokesperson for Taotian Group responded by stating that Taobao and Tmall have always adhered to the open cooperation concept, actively exploring interoperability with various platforms, continuously improving the shopping experience for consumers, making shopping more convenient, enjoyable, and efficient for consumers.
Alipay also responded by stating that openness, cooperation, innovation, and sharing are the basic spirits of the Internet and the overall trend of industry development. Alipay will continue to deepen strategic cooperation with Taotian Group, increase technological and product innovations, and continue to create greater value for merchants and consumers.
Related Articles

HK Stock Market Move | AKESO (09926) rose more than 7% in early trading. The company's first dual-immune ADC drug AK146D1 entered clinical trials.

HK Stock Market Move | SIMCERE PHARMA(02096) rises more than 3%. The new generation of anti-VEGF monoclonal antibody "Suvixitumab monoclonal antibody" has been approved for listing.

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.
HK Stock Market Move | AKESO (09926) rose more than 7% in early trading. The company's first dual-immune ADC drug AK146D1 entered clinical trials.

HK Stock Market Move | SIMCERE PHARMA(02096) rises more than 3%. The new generation of anti-VEGF monoclonal antibody "Suvixitumab monoclonal antibody" has been approved for listing.

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025